Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Zhongxin Fruit and Juice Shares Halted on SGX-ST Pending Announcement

Zhongxin Fruit and Juice Shares Halted on SGX-ST Pending Announcement

BitgetBitget2026/10/27 05:08
  • Zhongxin Fruit and Juice requested an immediate trading halt in its shares pending an announcement.
  • The shares (5EG) are listed on Singapore Exchange Securities Trading (SGX-ST). Related securities were also halted.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhongxin Fruit and Juice Limited published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 6WB49FI65IH21PSY) on October 27, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Deutsche Bank believes that the continuously expanding chip trade surplus in Asia is becoming a supporting force for the US dollar, as related profits are increasingly being reinvested into the US stock market.

智通财经•2026/11/16 23:03
The "chip dollar" is on the rise! Deutsche Bank: Asia's chip trade surplus flows into US stocks, becoming a new pillar for the dollar

Roche's (RHHBY.US) new breast cancer drug Wilserdly approved by FDA: Analysts predict peak annual sales could reach up to $14.5 billion

Roche's (RHHBY.US) new oral breast cancer drug has been approved by U.S. regulators, paving the way for this medication, which the pharmaceutical company hopes will transform the treatment of the disease.

智通财经•2026/11/16 22:53

Soros Family Office Leads in Reducing Nvidia Holdings, Top Billionaires Cashed Out Quietly Before Jensen Huang's Departure

Several ultra-high-net-worth family offices collectively reduced their holdings in Nvidia during Q3, including the Soros Family Office, BlueCrest, and Abu Dhabi sovereign investment institutions. This move secured profits just before CEO Jensen Huang was dismissed by the board on November 12 due to an extramarital affair scandal. More than ten institutions participated in the reduction, although all retained some holdings, with the combined market value of their shares still exceeding $1 billion. Meanwhile, some institutions continued to increase their positions against the trend.

华尔街见闻•2026/11/16 22:41